Fate Therapeutics, Inc. (FATE) Q4 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fate Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.069 -- 00:00:04.452 welcome to the fate therapeutics fourth quarter 2022 financial results conference call 00:00:04.452 -- 00:00:08.516 at this time all participants are on a listen-only mode this call is being webcast live 00:00:08.516 -- 00:00:12.319 on the investor section of fate's website at fatetherapeutics.com 00:00:12.319 -- 00:00:16.322 as a reminder today's call is being recorded i would like to introduce scott walshco 00:00:16.322 -- 00:00:19.364 president and ceo of fate therapeutics 00:00:19.364 -- 00:00:23.787 thank you good afternoon and thanks everyone for joining us for the fate therapeutics 00:00:23.787 -- 00:00:26.489 fourth quarter 2022 financial 00:00:26.489 -- 00:00:27.890 results call 00:00:27.890 -- 00:00:32.974 Shortly after 4 p.m. Eastern time today, we issued a press release with these results, 00:00:32.974 -- 00:00:37.477 which can be found on the investor section of our website under press releases. 00:00:37.477 -- 00:00:42.890 In addition, our Form 10-K for the year ended December 31, 2022, 00:00:43.422 -- 00:00:48.246 was filed shortly thereafter and can be found on the investor section of our website 00:00:48.246 -- 00:00:50.468 under financial information. 00:00:50.468 -- 00:00:54.491 Before we begin, I'd like to remind everyone that except for statements of historical 00:00:54.491 -- 00:00:59.903 facts, The statements made by management and responses to questions on this conference 00:00:59.903 -- 00:01:04.926 call are forward looking statements under the safe harbor provisions of the 00:01:04.926 -- 00:01:07.847 Private Securities Litigation Reform Act of 1995. 00:01:07.847 -- 00:01:09.728 These 00:01:09.728 -- 00:01:15.411 statements involve risks and uncertainties that can cause actual results to differ materially ...